Provence Wealth Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$391K Buy
830
+131
+19% +$60.6K 0.21% 100
2023
Q3
$304K Buy
699
+125
+22% +$56.7K 0.19% 103
2023
Q2
$255K Sell
574
-49
-8% -$22.6K 0.15% 127
2023
Q1
$286K Buy
623
+173
+38% +$82.3K 0.19% 107
2022
Q4
$231K Buy
+450
New +$228K 0.19% 107

Other funds holding ELV

Provence Wealth Management Group's ELV Position: Q4 2023 in Review

Provence Wealth Management Group increased its Elevance Health (ELV) stake by 19% in Q4 2023, buying an estimated $60.6K and bringing the position to 830 shares worth $391K. The position accounts for 0.21% of the portfolio, ranked #100.

Provence Wealth Management Group first reported a position in ELV in Q4 2022 and has held it in 5 quarters since. 1,656 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Provence Wealth Management Group held 830 shares of Elevance Health worth $391K as of Q4 2023.
  • Provence Wealth Management Group bought 131 Elevance Health shares in Q4 2023, an estimated $60.6K.
  • Elevance Health made up 0.21% of Provence Wealth Management Group's portfolio in Q4 2023, its #100 holding.
  • Provence Wealth Management Group first reported a position in Elevance Health in Q4 2022 and has held it in 5 quarters since.
  • 1,656 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.